Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
5.74
-0.48 (-7.72%)
At close: Oct 30, 2026, 4:00 PM EDT
5.85
+0.11 (1.92%)
After-hours: Oct 30, 2026, 6:36 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $455.93 million as of October 30, 2026. It is the 14,441st most valuable company in the world and the 2,756th biggest in the United States. Its market cap has decreased by 52.50% in one year.
Market Cap
455.93M
Enterprise Value
826.82M
1-Year Change
-52.50%
Global Rank
Country Rank
#2,756 United States
Category
ChartMarket Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has decreased from $527.13M to $455.93M, a decrease of -13.51%. That is a compound annual growth rate of -2.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 455.93M | -61.37% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 529.55M |
| BlossomHill Therapeutics | 523.18M |
| CytomX Therapeutics | 514.24M |
| Indaptus Therapeutics | 511.43M |
| Arvinas | 496.94M |
| Faeth Therapeutics | 496.14M |
| Oculis Holding AG | 492.62M |
| Monopar Therapeutics | 492.61M |